Guidant gets clearance for biliary stent

Interventional firm Guidant has received Food and Drug Administration clearance for its OmniLink .035 biliary stent system. The new system is designed to treat malignant biliary obstructions, according to Guidant of Indianapolis.

The stent system is compatible with a 0.035-inch guide wire, and features a new, thinner Xcelon balloon material, which is designed to give the delivery system a lower profile to enable users to create a smaller puncture site, according to the vendor. Guidant offers OmniLink .035 with two diameter-specific stents for different-sized blockages. The smaller stent has inner diameters of 5-7 mm, while the larger stent has inner diameters of 8-10 mm.

By AuntMinnie.com staff writers
June 20, 2001

Related Reading

Guidant begins carotid artery stent trial, December 22, 2000

Guidant seeks FDA approval for intravascular radiotherapy system, December 22, 2000

Guidant begins cerebrovascular stenting trial, November 13, 2000

Guidant stent for large arteries cleared for market, September 11, 2000

Copyright © 2001 AuntMinnie.com

Page 1 of 181
Next Page